Vitreoretinal Surgery Devices Market Thumbnail Image


Vitreoretinal Surgery Devices Market

Vitreoretinal Surgery Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product, by Surgery Type, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

LS : Medical Devices & Supplies

Select an option
Author's: NA | Roshan Deshmukh
Publish Date:

Get Sample to Email

Vitreoretinal Surgery Devices Market Research, 2033

The global vitreoretinal surgery devices market size was valued at $2.3 billion in 2023, and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033. The major factors driving the growth of the vitreoretinal surgery devices market are rising prevalence of retinal disorders such as diabetic retinopathy and macular degeneration, advancements in surgical technologies, and increasing geriatric population. In addition, the growing awareness and early diagnosis of retinal diseases, along with the development of healthcare infrastructure in emerging economies, contribute to market growth

Vitreoretinal Surgery Devices Market

Market Introduction and Definition

Vitreoretinal surgery devices are specialized tools and equipment used in ophthalmic surgeries that focus on the retina and vitreous humor of the eye. These devices are crucial for treating a variety of retinal conditions, including retinal detachments, macular holes, diabetic retinopathy, and epiretinal membranes. The primary goal of these surgeries is to repair and restore the normal anatomy and function of the retina, thus improving or stabilizing vision. The advancement of vitreoretinal surgery devices has enhanced the precision, safety, and efficacy of these procedures. Modern devices incorporate cutting-edge technology that allows for minimally invasive techniques, reducing recovery times and improving patient outcomes. The development of high-resolution imaging and visualization tools has enabled surgeons to perform intricate procedures with greater accuracy, while improved fluid management systems have optimized the control of the surgical environment.

Key Takeaways 

  • The vitreoretinal surgery devices market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major vitreoretinal surgery devices industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.

Key Market Dynamics

According to vitreoretinal surgery devices market forecast analysis the key factors driving the growth of the market are aging population, rising prevalence of ophthalmic disorders, and technological advancement. According to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over. By 2050, the world population of people aged 60 years and older is projected to be 2.1 billion. As individuals age, they become more susceptible to various eye conditions, such as age-related macular degeneration (AMD) , diabetic retinopathy, and retinal detachment, all of which often necessitate surgical intervention. The aging process itself contributes to changes in the vitreous and retina, making elderly individuals more prone to conditions that require sophisticated surgical procedures like vitrectomy, a common intervention for repairing retinal detachments or removing scar tissue from the retina. Thus, the rise in the geriatric population is expected to drive the vitreoretinal surgery devices market growth. Furthermore, a rise in the prevalence of ophthalmic diseases is expected to drive the growth of the market.  Ophthalmic diseases, particularly those affecting the retina and vitreous humor of the eye, such as diabetic retinopathy, age-related macular degeneration (AMD) , and retinal detachment, have shown increasing incidence rates globally. These conditions often lead to severe visual impairment or even blindness if left untreated, necessitating surgical interventions to restore or preserve vision. Thus, the ageging population and rise in prevalence of opthalmic diseases is expected to drive the growth of vitreoretinal surgery devices market size.

Vitreoretinal surgery has become a crucial therapeutic approach for managing these complex eye conditions. The demand for vitreoretinal surgery devices, including instruments and equipment used in procedures like vitrectomy and retinal detachment repair, has correspondingly risen. Technological advancements in vitrectomy system have improved surgical outcomes, allowing for more precise and minimally invasive procedures that reduce patient recovery times and improve post-operative results. Thus, the rise in prevalence of ophthalmic diseases and technological advancement in the vitreoretinal surgery devices is expected to drive the growth of the market.

Rise in Geriatric Population

According to the vitreoretinal surgery devices market opportunity analysis rise in the geriatric population is increasingly recognized as a pivotal driver for the vitreoretinal surgery devices market. As the global population ages, there is a proportional increase in age-related eye conditions such as diabetic retinopathy, age-related macular degeneration (AMD) , and retinal detachment. These conditions often necessitate surgical interventions to restore or preserve vision, thereby boosting the demand for vitreoretinal surgery devices. Elderly individuals are more susceptible to these conditions due to physiological changes in the eye, such as the thickening of the vitreous gel or the formation of retinal scars. Consequently, there is a growing need for advanced surgical tools and techniques that cater specifically to the delicate procedures required for treating these ailments in older patients. According to 2023 article by National Library of Medicine, the overall prevalence of age-related macular degeneration was highest among the 60- to 69-year age group.

Vitreoretinal Surgery Devices Market by

Market Segmentation

The vitreoretinal surgery devices industry is segmented into product, surgery type, end user, and region. By product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. By surgery type, the market is classified into anterior vitreoretinal surgery and posterior vitreoretinal surgery.
By end user, the market is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Regional/Country Market Outlook

North America dominated the vitreoretinal surgery devices market share in 2023 owing to substantial research and development activities, a strong presence of major key players, well-established healthcare systems, high adoption of advanced medical technologies, and increasing prevalence of age-related macular degeneration (AMD) and diabetic retinopathy. In the Asia-Pacific region, rapid market expansion is anticipated due to improving healthcare infrastructure, rising healthcare expenditures, and increasing awareness among the population regarding eye health. Countries like China and India are witnessing significant market growth due to large patient pools and increasing healthcare investments.

  • According to the factsheet published by Bright Focus Foundation in October 2022, about 11 million people in the U.S. have some form of age-related macular degeneration and this number is expected to double to nearly 22 million by 2050.
  • According to 2022 fact sheet by National Center of Biotechnology Information (NCBI) in 2022, it was estimated that 55.9 million people suffer age-related macular degeneration (AMD) in China. 
  • According to an article published by United Nations Population Fund, by 2050, one in four people in Asia and the Pacific will be over 60 years old

Competitive Landscape

The major players operating in the vitreoretinal surgery devices market include vitreoretinal surgery devices market report summarizes top key players overview as Bausch & Lomb Incorporated, Novartis AG (Alcon) , Inami & Co., Paragon Care Group Pty Ltd, Oculus Inc., MedOne Surgical, Inc., Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson and Blink Medical. Other players in the vitreoretinal surgery devices market are Hoya Surgical Optics, Haag-Streit Group, Ellex Medical Lasers and BVI. 

Recent Key Strategies and Developments

  • In March 2022, Carl Zeiss Meditec received 510 (k) premarket approval from the United States Food and Drug Administration (FDA) for their QUATERA 700 device, which is indicated for the emulsification and removal of cataracts and anterior segment vitrectomy.
  • In May 2022, Alcon announced the launch of their Constellation Vision System, which is a new generation of vitreoretinal surgery platform that offers a variety of technological advances, such as improved visualization and more precise instrumentation.
  • In June 2022, Ellex Medical Lasers announced the launch of their EYESYS 23G Vitrectomy System, which is a new minimally invasive vitreoretinal surgery system that is designed to provide surgeons with a more precise and efficient way to perform vitreoretinal surgery procedures.

Key Sources Referred

  1. National Library of Medicine
  2. Bright Focus Foundation
  3. Center of Disease Control and Prevention
  4. National Center of Biotechnology Information
  5. United Nations Population Fund
  6. Now Health International
  7. World Health Organization

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vitreoretinal surgery devices market analysis from 2024 to 2033 to identify the prevailing vitreoretinal surgery devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the vitreoretinal surgery devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global vitreoretinal surgery devices market trends, key players, market segments, application areas, and market growth strategies.

Vitreoretinal Surgery Devices Market Report Highlights

Aspects Details
Market Size By 2033

USD 4.1 Billion

Growth Rate

CAGR of 5.9%

Forecast period

2024 - 2033

Report Pages


By Product
  • Perfluorocarbon Liquids
  • Endoillumination Instrument
  • Vitreoretinal Prefilled Silicone Oil Syringes
  • Vitrectomy System
  • Other
By Surgery Type
  • Anterior Vitreoretinal Surgery
  • Posterior Vitreoretinal Surgery
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players

Johnson & Johnson, Carl Zeiss Meditec AG, Inami & Co, MedOne Surgical, Inc, Peregrine Surgical, Novartis AG, Blink Medical, Paragon Care Group Pty Ltd, Bausch & Lomb, Oculus Inc

Author Name(s) : NA | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Vitreoretinal Surgery Devices Market is $2.3 billion in 2023.

The forecast period for Vitreoretinal Surgery Devices Market is 2024-2033.

The base year is 2023 in Vitreoretinal Surgery Devices Market

The market value of Vitreoretinal Surgery Devices Market is projected to reach $4.1 Billion by 2033.

Major key players that operate in the Vitreoretinal Surgery Devices Market are Bausch & Lomb Incorporated, MedOne Surgical, Inc and Novartis AG

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Vitreoretinal Surgery Devices Market

Global Opportunity Analysis and Industry Forecast, 2024-2033